COURTNEY EDWARDS: Open Payments
NPI 1447669460 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 32 payments from 16 companies in 2025. Trend: 2023 $1,209 · 2024 $680 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Janssen Biotech, Inc. | 3 | $58 |
| Geron Corporation | 2 | $53 |
| SOBI, INC | 2 | $41 |
| PFIZER INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Genentech USA, Inc. | 1 | $23 |
| Celgene Corporation | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
Products named: IMBRUVICA, EPKINLY, Venclexta, RYTELO, ICLUSIG, Vonjo, ELREXFIO, AYVAKIT.
Industry payments across CO — which companies pay providers there.
